Listen time: 13m 35s

Jonathan Hill, James Spratt, Charalambos Antoniades, et al

Watch time: 11h 6m 44s (20 videos)

About

Transcatheter therapy of structural heart disease is advancing rapidly. Due to the less invasive approach, transcatheter techniques have replaced surgery as the standard procedure for atrial septal defect and patent foramen ovale closure.

Evolving interventional techniques allow treatment of paravalvular leaks, ventricular septal defects and valve replacement, especially the rapid evolution and newer indications for transcatheter aortic valve replacement (TAVR).

Articles

A39 - Left Ventricular Assist Device Implantation after Extracorporeal Membrane Oxygenation Therapy and Subsequent Impella 5.0 Therapy: A Multicentre Analysis

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A39.

A38 - Impella 5.0 Treatment as a Bridge-to-decision Option after Extracorporeal Life Support in Patients with an Unclear Neurological Outcome

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A38.

A37 - Peri-procedural Ventricular Unloading with Impella Optimises Outcomes in High-risk Patients at a Community Hospital

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A37.

A34 - Impact of Mitral and Aortic Valve Regurgitation on the Right Ventricular Shape and Function: A 3D Echocardiography Study

Published:

11 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 1):A34.